BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 38045567)

  • 1. Tissue factor targeting peptide enhances nanoparticle binding and delivery of a synthetic specialized pro-resolving lipid mediator to injured arteries.
    Levy ES; Kim AS; Werlin E; Chen M; Sansbury BE; Spite M; Desai TA; Conte MS
    JVS Vasc Sci; 2023; 4():100126. PubMed ID: 38045567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 17R/S-Benzo-RvD1, a synthetic resolvin D1 analogue, attenuates neointimal hyperplasia in a rat model of acute vascular injury.
    Kim AS; Werlin EC; Kagaya H; Chen M; Wu B; Mottola G; Jan M; Conte MS
    PLoS One; 2022; 17(2):e0264217. PubMed ID: 35226675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perivascular delivery of resolvin D1 inhibits neointimal hyperplasia in a rat model of arterial injury.
    Wu B; Mottola G; Chatterjee A; Lance KD; Chen M; Siguenza IO; Desai TA; Conte MS
    J Vasc Surg; 2017 Jan; 65(1):207-217.e3. PubMed ID: 27034112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perivascular delivery of resolvin D1 inhibits neointimal hyperplasia in a rabbit vein graft model.
    Wu B; Werlin EC; Chen M; Mottola G; Chatterjee A; Lance KD; Bernards DA; Sansbury BE; Spite M; Desai TA; Conte MS
    J Vasc Surg; 2018 Dec; 68(6S):188S-200S.e4. PubMed ID: 30064835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unidirectional and sustained delivery of the proresolving lipid mediator resolvin D1 from a biodegradable thin film device.
    Lance KD; Chatterjee A; Wu B; Mottola G; Nuhn H; Lee PP; Sansbury BE; Spite M; Desai TA; Conte MS
    J Biomed Mater Res A; 2017 Jan; 105(1):31-41. PubMed ID: 27508346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proresolving Lipid Mediators Resolvin D1 and Protectin D1 Isomer Attenuate Neointimal Hyperplasia in the Rat Carotid Artery Balloon Injury Model.
    Makino Y; Miyahara T; Nitta J; Miyahara K; Seo A; Kimura M; Suhara M; Akai A; Akagi D; Yamamoto K; Hoshina K
    J Surg Res; 2019 Jan; 233():104-110. PubMed ID: 30502235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral Resolvin D1 attenuates early inflammation but not intimal hyperplasia in a rat carotid angioplasty model.
    Mottola G; Werlin EC; Wu B; Chen M; Chatterjee A; Schaller MS; Conte MS
    Prostaglandins Other Lipid Mediat; 2020 Feb; 146():106401. PubMed ID: 31841663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 17(R)-resolvin D1 specifically inhibits transient receptor potential ion channel vanilloid 3 leading to peripheral antinociception.
    Bang S; Yoo S; Yang TJ; Cho H; Hwang SW
    Br J Pharmacol; 2012 Feb; 165(3):683-92. PubMed ID: 21718307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aspirin-triggered resolvin D1 attenuates PDGF-induced vascular smooth muscle cell migration via the cyclic adenosine monophosphate/protein kinase A (cAMP/PKA) pathway.
    Mottola G; Chatterjee A; Wu B; Chen M; Conte MS
    PLoS One; 2017; 12(3):e0174936. PubMed ID: 28362840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective actions of aspirin-triggered (17R) resolvin D1 and its analogue, 17R-hydroxy-19-para-fluorophenoxy-resolvin D1 methyl ester, in C5a-dependent IgG immune complex-induced inflammation and lung injury.
    Tang H; Liu Y; Yan C; Petasis NA; Serhan CN; Gao H
    J Immunol; 2014 Oct; 193(7):3769-78. PubMed ID: 25172497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proresolving and cartilage-protective actions of resolvin D1 in inflammatory arthritis.
    Norling LV; Headland SE; Dalli J; Arnardottir HH; Haworth O; Jones HR; Irimia D; Serhan CN; Perretti M
    JCI Insight; 2016 Apr; 1(5):e85922. PubMed ID: 27158677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proresolving actions of a new resolvin D1 analog mimetic qualifies as an immunoresolvent.
    Orr SK; Colas RA; Dalli J; Chiang N; Serhan CN
    Am J Physiol Lung Cell Mol Physiol; 2015 May; 308(9):L904-11. PubMed ID: 25770181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of the inflammatory response by vascular grafts modified with Aspirin-Triggered Resolvin D1 promotes blood vessel regeneration.
    Shi J; Zhang X; Jiang L; Zhang L; Dong Y; Midgley AC; Kong D; Wang S
    Acta Biomater; 2019 Oct; 97():360-373. PubMed ID: 31351251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapamycin-loaded nanoparticles for inhibition of neointimal hyperplasia in experimental vein grafts.
    Zou J; Zhang X; Yang H; Zhu Y; Ma H; Wang S
    Ann Vasc Surg; 2011 May; 25(4):538-46. PubMed ID: 21549923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel anti-inflammatory and pro-resolving role for resolvin D1 in acute cigarette smoke-induced lung inflammation.
    Hsiao HM; Sapinoro RE; Thatcher TH; Croasdell A; Levy EP; Fulton RA; Olsen KC; Pollock SJ; Serhan CN; Phipps RP; Sime PJ
    PLoS One; 2013; 8(3):e58258. PubMed ID: 23484005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and characterization of tumor-targeted copolymer nanocarrier modified by transferrin.
    Liu R; Wang Y; Li X; Bao W; Xia G; Chen W; Cheng J; Xu Y; Guo L; Chen B
    Drug Des Devel Ther; 2015; 9():2705-19. PubMed ID: 26045659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resolvin D1 attenuates Ang II-induced hypertension in mice by inhibiting the proliferation, migration and phenotypic transformation of vascular smooth muscle cells by blocking the RhoA/mitogen-activated protein kinase pathway.
    Wei C; Zhang J; Peng S; Liu J; Xu Y; Zhao M; Xu S; Pan W; Yin Z; Zheng Z; Qin JJ; Wan J; Wang M
    J Hypertens; 2024 Mar; 42(3):420-431. PubMed ID: 37937508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A pH/ROS dual-responsive and targeting nanotherapy for vascular inflammatory diseases.
    Zhang R; Liu R; Liu C; Pan L; Qi Y; Cheng J; Guo J; Jia Y; Ding J; Zhang J; Hu H
    Biomaterials; 2020 Feb; 230():119605. PubMed ID: 31740099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resolvin D1 Alleviates Mechanical Allodynia via ALX/FPR2 Receptor Targeted Nod-like Receptor Protein 3/Extracellular Signal-Related Kinase Signaling in a Neuropathic Pain Model.
    Wang YH; Gao X; Tang YR; Chen FQ; Yu Y; Sun MJ; Li Y
    Neuroscience; 2022 Jul; 494():12-24. PubMed ID: 35487301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mesenchymal stem cells loaded with paclitaxel-poly(lactic-
    Wang X; Gao J; Ouyang X; Wang J; Sun X; Lv Y
    Int J Nanomedicine; 2018; 13():5231-5248. PubMed ID: 30237710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.